Literature DB >> 11740829

Vasculitic complications associated with coccidioidal meningitis.

P L Williams1.   

Abstract

Vasculitis complicating coccidioidal meningitis is becoming increasingly recognized. At this time, predisposing clinical features have not been elucidated. Histologically, 2 types of vascular inflammation have been described. The first is a transmural inflammatory process of the intracranial blood vessels that occurs early in the course of disease. Encroachment of the vessel lumen may result in thrombosis. The second process occurs with chronic disease and is associated with intimal thickening and luminal occlusion with little inflammation. Numerous substances, including metalloproteinases, cytokines such as tumor necrosis factor (TNF)-alpha, and an elastase, have been postulated as putative virulence factors. Recently, a rabbit model has been developed that appears to closely mimic human disease. By using this model, a parallel between coccidioidal vasculitis and temporal arteritis has been developed. Currently, there are no established therapies for coccidioidal vasculitis. The use of corticosteroids is controversial. Of interest are agents that may block the pathologic process, such as omega-3 oils, and pentoxyfylline. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11740829     DOI: 10.1053/srin.2001.29319

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  7 in total

Review 1.  Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications.

Authors:  Royce Johnson; Jackie Ho; Pete Fowler; Arash Heidari
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-13       Impact factor: 5.081

2.  Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.

Authors:  George R Thompson; Janis E Blair; Sharon Wang; Robert Bercovitch; Michael Bolaris; Dane Van Den Akker; Rodrigo Lopez; Arash Heidari; Antonino Catanzaro; Jose Cadena; Peter Chin-Hong; Brad Spellberg; Royce Johnson
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

3.  Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.

Authors:  Karl V Clemons; Javier Capilla; Raymond A Sobel; Marife Martinez; Ann-Jay Tong; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

4.  Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Authors:  K E Zucker; P Kamberi; R A Sobel; G Cloud; D N Meli; K V Clemons; D A Stevens; P L Williams; S L Leib
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

5.  Coccidioidal meningitis: update on epidemiology, clinical features, diagnosis, and management.

Authors:  Janis E Blair
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

6.  Coccidioidal meningitis complicated by central nervous system vasculitis in a patient with leukemia.

Authors:  Dany Tager; Anne Hatch; Jennifer Segar; Brentin Roller; Mayar Al Mohajer; Tirdad T Zangeneh
Journal:  Med Mycol Case Rep       Date:  2017-03-23

Review 7.  Central Nervous System Infections Due to Coccidioidomycosis.

Authors:  Niki R Jackson; Janis E Blair; Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2019-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.